These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6029136)

  • 1. Screening for cervical cancer.
    Br Med J; 1967 Jun; 2(5555):782-3. PubMed ID: 6029136
    [No Abstract]   [Full Text] [Related]  

  • 2. Cervical screening for carcinoma: a comparison of cytological and enzyme (6-phosphogluconate dehydrogenase) methods and clinical findings.
    Boyd JT; Gibbs DF; Labrum AH; Philps FR
    Br Med J; 1967 Jun; 2(5555):785-92. PubMed ID: 6029138
    [No Abstract]   [Full Text] [Related]  

  • 3. Technical modifications of the 6-phosphogluconate dehydrogenase test of the vaginal fluid.
    Sanner T; Bergsjo P; Koller O; Kolstad P; Pihl A
    Am J Obstet Gynecol; 1967 Jul; 98(6):800-3. PubMed ID: 6027708
    [No Abstract]   [Full Text] [Related]  

  • 4. Carcinoma of the cervix. Automated methods for cancer screening.
    Husain OA; Cameron CB
    Proc R Soc Med; 1966 Oct; 59(10):982-6. PubMed ID: 5955773
    [No Abstract]   [Full Text] [Related]  

  • 5. 6-phosphogluconate dehydrogenase (6PGD) activity in the cervical mucus and vaginal fluid in benign and malignant gynaecological lesions.
    Brooks PC; Muir GG
    J Obstet Gynaecol Br Commonw; 1967 Feb; 74(1):111-4. PubMed ID: 6018084
    [No Abstract]   [Full Text] [Related]  

  • 6. The source of 6-phosphogluconate dehydrogenase in vaginal fluid samples.
    Churchouse MJ; Carter GN; Bonham DG
    J Obstet Gynaecol Br Commonw; 1967 Oct; 74(5):712-22. PubMed ID: 6058534
    [No Abstract]   [Full Text] [Related]  

  • 7. Detection of preinvasive and early invasive cancer by 6-phosphogluconate dehydrogenase determinations.
    Kolstad P; Bergsjo P; Koller O; Pihl A; Sanner T
    Am J Obstet Gynecol; 1967 Jul; 98(6):804-7. PubMed ID: 6027709
    [No Abstract]   [Full Text] [Related]  

  • 8. Mass screening for cancer and precancerous conditions of cervix uteri. A preliminary report.
    Messelt OT; Höeg K
    Acta Cytol; 1967; 11(1):39-40. PubMed ID: 5230439
    [No Abstract]   [Full Text] [Related]  

  • 9. LABORATORY DIAGNOSIS OF EARLY MALIGNANT DISEASE. NEW DIAGNOSTIC TESTS FOR CANCER OF THE UTERUS.
    BONHAM DG
    Trans Med Soc Lond; 1964; 80():30-41. PubMed ID: 14270933
    [No Abstract]   [Full Text] [Related]  

  • 10. Mass cervical cancer screening program by irrigation smear in Japan.
    Kawashima Y; Ino S; Tashiro K; Tachibana M; Masukawa T
    Obstet Gynecol; 1968 Jul; 32(1):17-23. PubMed ID: 5742086
    [No Abstract]   [Full Text] [Related]  

  • 11. Cytology screening--a program that works.
    MacLean MA
    Can Nurse; 1969 May; 65(5):40-3. PubMed ID: 5769363
    [No Abstract]   [Full Text] [Related]  

  • 12. The early diagnosis of carcinoma of the female genital tract. II. Vaginal fluid 6-phosphogluconate dehydrogenase activity as a test for carcinoma of the cervix.
    Moukter M; Higgins G
    J Obstet Gynaecol Br Commonw; 1965 Oct; 72(5):684-90. PubMed ID: 5891592
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter: Screening for cervical cancer.
    Lancet; 1974 Jun; 1(7868):1221. PubMed ID: 4134347
    [No Abstract]   [Full Text] [Related]  

  • 14. Challenges in screening for cancer of the cervix: delivery, technology and evaluation of programs.
    Morgan PP
    Can Med Assoc J; 1982 Oct; 127(7):571-2. PubMed ID: 7127224
    [No Abstract]   [Full Text] [Related]  

  • 15. Screening for cervical cancer. Canadian programmatic guidelines.
    Parboosingh J
    Can Fam Physician; 1999 Feb; 45():383-93. PubMed ID: 10065312
    [No Abstract]   [Full Text] [Related]  

  • 16. [Vaginal-cytological examination. Routine examination of a symptom-free young clientele].
    Hastrup J; Rojel K
    Ugeskr Laeger; 1968 Feb; 130(6):243-5. PubMed ID: 5676294
    [No Abstract]   [Full Text] [Related]  

  • 17. Novel technologies for cervical cancer screening seen on the horizon.
    McNeil C
    J Natl Cancer Inst; 1995 Jun; 87(11):789-90. PubMed ID: 7791225
    [No Abstract]   [Full Text] [Related]  

  • 18. [Results of mass screening for cervical cancer performed at the Centro di Citoistodiagnostica degli Spedali Civili in Brescia].
    Gastaldi A; Cavaglieri D; Zorzi M; Arrigoni GA
    Ann Ostet Ginecol Med Perinat; 1969 Mar; 91(3):163-81. PubMed ID: 5362491
    [No Abstract]   [Full Text] [Related]  

  • 19. 6-PHOSPHOGLUCONATE DEHYDROGENASE ACTIVITY IN VAGINAL FLUID: LIMITATIONS AS A SCREENING TEST FOR GENITAL CANCER.
    CAMERON CB; HUSAIN OA
    Br Med J; 1965 Jun; 1(5449):1529-30. PubMed ID: 14288104
    [No Abstract]   [Full Text] [Related]  

  • 20. False negative rate in mass screening for cervical cancer.
    Sato S; Mikino H; Matsunaga G; Yajima A
    Acta Cytol; 1998; 42(3):836-7. PubMed ID: 9622728
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.